Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1966 1
1967 1
1973 1
1980 1
1981 3
1983 1
1986 1
1988 1
1989 6
1990 4
1991 1
1993 1
1994 5
1995 8
1996 9
1997 4
1998 5
1999 10
2000 10
2001 8
2002 8
2003 8
2004 8
2005 10
2006 11
2007 9
2008 7
2009 6
2010 10
2011 12
2012 12
2013 17
2014 17
2015 9
2016 11
2017 12
2018 18
2019 10
2020 7
2021 8
2022 11
2023 8
2024 12
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

299 results

Results by year

Filters applied: . Clear all
Page 1
Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS.
Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chiò A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S; VALOR and OLE Working Group. Miller TM, et al. N Engl J Med. 2022 Sep 22;387(12):1099-1110. doi: 10.1056/NEJMoa2204705. N Engl J Med. 2022. PMID: 36129998 Free article. Clinical Trial.
Phase 1/2a clinical trial in ALS with ropinirole, a drug candidate identified by iPSC drug discovery.
Morimoto S, Takahashi S, Ito D, Daté Y, Okada K, Kato C, Nakamura S, Ozawa F, Chyi CM, Nishiyama A, Suzuki N, Fujimori K, Kondo T, Takao M, Hirai M, Kabe Y, Suematsu M, Jinzaki M, Aoki M, Fujiki Y, Sato Y, Suzuki N, Nakahara J; Pooled Resource Open-Access ALS Clinical Trials Consortium; Okano H. Morimoto S, et al. Among authors: date y. Cell Stem Cell. 2023 Jun 1;30(6):766-780.e9. doi: 10.1016/j.stem.2023.04.017. Cell Stem Cell. 2023. PMID: 37267913 Free article. Clinical Trial.
p53 Deficiency-Dependent Oncogenicity of Runx3.
Ito K, Otani S, Date Y. Ito K, et al. Among authors: date y. Cells. 2023 Apr 10;12(8):1122. doi: 10.3390/cells12081122. Cells. 2023. PMID: 37190031 Free PMC article. Review.
Defective neutrophil clearance in JAK2V617F myeloproliferative neoplasms drives myelofibrosis via immune checkpoint CD24.
Khatib-Massalha E, Di Buduo CA, Chédeville AL, Ho YH, Zhu Y, Grockowiak E, Date Y, Khuat LT, Fang Z, Quesada-Salas J, Carrillo Félez E, Migliavacca M, Montero I, Pérez-Simón JA, Balduini A, Méndez-Ferrer S. Khatib-Massalha E, et al. Among authors: date y. Blood. 2025 Aug 7;146(6):717-731. doi: 10.1182/blood.2024027455. Blood. 2025. PMID: 40373279
299 results